Thursday , August 22 2019
  • Loading stock data...

Home / Health / On marijuana and opioids — the DEA has no clue what it’s talking about

On marijuana and opioids — the DEA has no clue what it’s talking about

By Paul Armentano

Is state-level medical cannabis access mitigating or fueling America’s opioid crisis? Testifying before Congress last week, Drug Enforcement Agency (DEA) acting administrator Robert Patterson claimed the latter. But when he prompted to provide evidence in support of the agency’s position, he acknowledged that he could not.

His failure to substantiate this claim is unsurprising. That is because numerous peer-reviewed studies show that increased cannabis access is associated with declining rates of opioid use, abuse, hospitalizations, and mortality. Among patients enrolled in state-sanctioned medical marijuana access programs, participants’ use of not only opioids, but also their use of numerous other prescription medications — such as anti-depressants and anti-anxiety drugs — declines significantly.

Read more at The Hill

About admin

Check Also

Cannabis Consumers Want Hollywood To Abandon Marijuana Stereotypes

By Mike Adams If Hollywood plans to capitalize on the average cannabis consumer, a new …

Leave a Reply

Your email address will not be published. Required fields are marked *

CONTACT US
Thank You. We will contact you as soon as possible.
SUBSCRIBE TO OUR NEWSLETTER
* we never share your e-mail with third parties.